𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma

✍ Scribed by Ben Davidson; Iris Goldberg; Walter H. Gotlieb; Juri Kopolovic; Gilad Ben-Baruch; Jahn M. Nesland; Aasmund Berner; Magne Bryne; Reuven Reich

Book ID
110240199
Publisher
Springer
Year
1999
Tongue
English
Weight
219 KB
Volume
17
Category
Article
ISSN
0262-0898

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of MMP-2 and MMP-9, their inh
Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas
✍ Jones, J. Louise; Glynn, P.; Walker, Rosemary A. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 321 KB πŸ‘ 2 views

Enhanced expression of the type IV collagenases MMP-2 and MMP-9, or lack of their inhibitors TIMP-1 and TIMP-2, has been associated with tumour invasion and metastatic potential in several experimental models. Regulation of enzyme activity is clearly a key step in tumour invasion, and recently a pot

Vascular endothelial growth factor expre
Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas
✍ Carine Munaut; AgnΓ¨s NoΓ«l; Olivier Hougrand; Jean-Michel Foidart; Jacques Bonive πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 340 KB πŸ‘ 1 views

Vascular endothelial growth factor (VEGF) is the major endothelial mitogen in central nervous system neoplasms and it is expressed in 64-95% of glioblastomas (GBMs). Tumour cells are the main source of VEGF in GBMs whereas VEGF receptors (VEGFR-1, its soluble form sVEGFR-1, VEGFR-2 and neuropilin-1)